From Multiomics to Mechanisms – Microbiome-Gut-Host Interactions as a Pathogenetic Driver of Parkinson's Disease Subtypes
Description of the granted funding
Parkinson's disease (PD) affects over 5 million people worldwide and 15.000 in Finland. The microbiota-gut-brain axis (MGBA) affects PD symptoms and pathology. Different subtypes of PD may exist with the location of first pathological changes being either in the brain (brain first) or the autonomic nervous system, specifically the gut (body first). Treatments that do not account for such differences will likely fail. We will identify subtypes of PD already in the prodromal phase (before motor symptoms appear) by analyzing genes, gut bacteria, metabolism, and inflammation to profile the MGBA in a large longitudinal cohort of elderly individuals and PD patients. We will compare MGBA pathway alterations (=biomarkers) across different subtypes and disease stages. We will confirm MGBA effects by assessing how fecal microbiota transplantation to rodent models worsens or alleviates PD pathology. This will eventually lead to new personalized treatments for PD.
Show moreStarting year
2021
End year
2025
Granted funding
Other information
Funding decision number
342758
Fields of science
Biomedicine
Research fields
Systeemibiologia, bioinformatiikka
Themes
Nuori tutkijasukupolvi 2020
Identified topics
brain, neuroscience